
Martin Handfield
President & Chief Executive Officer
Dr. Handfield is a serial entrepreneur with more than 28 years of biotech experience. After beginning his career as a Postdoctoral Associate in the University of Florida’s College of Dentistry, he rose to Tenured Associate Professor during his 14-year tenure at UF. Across industry roles, he has led scientific, preclinical, and clinical development for multiple therapeutic platforms, from anti-infectives to vaccines to live biotherapeutics, including several programs that reached first-in-human status or were advanced as new biological entities at the FDA and EMEA. He spent 14 years as Chief Scientific Officer at Oragenics (NYSE: OGEN) and currently serves as an Entrepreneur in Residence with UF-Innovate. Dr. Handfield holds a BS in Biochemistry and MS and PhD degrees in Microbiology and Immunology.
